Assems Inc. (KOSDAQ:136410)
South Korea · Delayed Price · Currency is KRW 3,670.00
-45.00 (-1.21%)
At close: Sep 23, 2026
Assems Revenue
Assems had revenue of 12.21B KRW in the quarter ending June 30, 2026, a decrease of -16.10%. This brings the company's revenue in the last twelve months to 54.44B, down -12.12% year-over-year. In the year 2025, Assems had annual revenue of 60.27B with 5.42% growth.
Revenue (ttm)
54.44B
Revenue Growth
-12.12%
P/S Ratio
0.71
Revenue / Employee
625.76M
Employees
87
Market Cap
38.44B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 60.27B | 3.10B | 5.42% |
| Dec 31, 2024 | 57.17B | 9.44B | 19.78% |
| Dec 31, 2023 | 47.73B | -5.32B | -10.02% |
| Dec 31, 2022 | 53.05B | 11.03B | 26.23% |
| Dec 31, 2021 | 42.03B | 7.98B | 23.43% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Seung Il | 145.86B |
| UST Co., Ltd. | 64.19B |
| Kyung Nam Pharm | 54.89B |
| Eagle Veterinary Technology Co.,Ltd | 44.73B |
| Bonne | 42.19B |
| Kolmar BioTech | 40.30B |
| iMBC Co.,Ltd. | 39.50B |
| Sangji Construction | 19.42B |